| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,260 |
3,851 |
$679K |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
1,602 |
328 |
$598K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,213 |
1,125 |
$249K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,321 |
4,054 |
$205K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
587 |
547 |
$83K |
| 80053 |
Comprehensive metabolic panel |
6,430 |
5,535 |
$82K |
| 87631 |
|
948 |
898 |
$77K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,957 |
5,754 |
$44K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
122 |
28 |
$44K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,768 |
1,590 |
$43K |
| 70450 |
Computed tomography, head or brain; without contrast material |
678 |
636 |
$33K |
| 71045 |
Radiologic examination, chest; single view |
1,506 |
1,394 |
$26K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,056 |
1,956 |
$25K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
191 |
181 |
$9K |
| 84703 |
|
1,597 |
1,437 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,538 |
1,922 |
$9K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
864 |
653 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,509 |
1,344 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
135 |
127 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,193 |
1,012 |
$7K |
| 84484 |
|
1,492 |
1,205 |
$7K |
| 81001 |
|
2,704 |
2,433 |
$6K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
163 |
150 |
$6K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
127 |
109 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
250 |
243 |
$5K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
593 |
503 |
$4K |
| 93976 |
|
78 |
66 |
$4K |
| 83690 |
|
1,415 |
1,269 |
$4K |
| 76801 |
|
45 |
36 |
$3K |
| 83880 |
|
210 |
199 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
67 |
61 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
80 |
78 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
129 |
125 |
$2K |
| 84702 |
|
152 |
117 |
$2K |
| 87634 |
|
27 |
25 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,653 |
1,372 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
927 |
711 |
$1K |
| 85610 |
|
742 |
675 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
17 |
17 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
30 |
27 |
$898.84 |
| 96376 |
|
120 |
93 |
$738.38 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
27 |
26 |
$704.38 |
| 85730 |
|
350 |
321 |
$695.38 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
768 |
694 |
$635.11 |
| 85379 |
|
111 |
103 |
$538.44 |
| 83735 |
|
246 |
182 |
$532.77 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15 |
15 |
$511.84 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
151 |
122 |
$507.59 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
179 |
118 |
$476.17 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
91 |
89 |
$428.76 |
| 83605 |
|
46 |
39 |
$353.93 |
| 86901 |
|
132 |
121 |
$221.95 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
16 |
16 |
$146.27 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
108 |
84 |
$142.35 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
115 |
89 |
$134.88 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
15 |
$127.29 |
| 36415 |
Collection of venous blood by venipuncture |
1,790 |
1,570 |
$83.80 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
43 |
41 |
$77.66 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$65.32 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
43 |
40 |
$22.53 |
| A9270 |
Non-covered item or service |
978 |
807 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
33 |
29 |
$0.00 |